Global Retinal Vein Occlusion Therapeutics Market Research Report 2019

Table of Contents

Executive Summary

1 Retinal Vein Occlusion Therapeutics Market Overview

• 1.1 Product Overview and Scope of Retinal Vein Occlusion Therapeutics
• 1.2 Retinal Vein Occlusion Therapeutics Segment by Type
  • 1.2.1 Global Retinal Vein Occlusion Therapeutics Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Aflibercept Biosimilar
  • 1.2.3 Aflibercept SR
  • 1.2.4 AKB-9778
  • 1.2.5 AP-01
  • 1.2.6 Others
• 1.3 Retinal Vein Occlusion Therapeutics Segment by Application
  • 1.3.1 Retinal Vein Occlusion Therapeutics Consumption Comparison by Application (2014-2025)
  • 1.3.2 Research Center
  • 1.3.3 Clinic
  • 1.3.4 Hospital
• 1.3 Global Retinal Vein Occlusion Therapeutics Market by Region
  • 1.3.1 Global Retinal Vein Occlusion Therapeutics Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Retinal Vein Occlusion Therapeutics Market Size
  • 1.4.1 Global Retinal Vein Occlusion Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Retinal Vein Occlusion Therapeutics Production (2014-2025)

2 Global Retinal Vein Occlusion Therapeutics Market Competition by Manufacturers

• 2.1 Global Retinal Vein Occlusion Therapeutics Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Retinal Vein Occlusion Therapeutics Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Retinal Vein Occlusion Therapeutics Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Retinal Vein Occlusion Therapeutics Production Sites, Area Served, Product Types
• 2.5 Retinal Vein Occlusion Therapeutics Market Competitive Situation and Trends
  • 2.5.1 Retinal Vein Occlusion Therapeutics Market Concentration Rate
  • 2.5.2 Retinal Vein Occlusion Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Retinal Vein Occlusion Therapeutics Production Market Share by Regions

• 3.1 Global Retinal Vein Occlusion Therapeutics Production Market Share by Regions
• 3.2 Global Retinal Vein Occlusion Therapeutics Revenue Market Share by Regions (2014-2019)
• 3.3 Global Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Retinal Vein Occlusion Therapeutics Production
  • 3.4.1 North America Retinal Vein Occlusion Therapeutics Production Growth Rate (2014-2019)
  • 3.4.2 North America Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Retinal Vein Occlusion Therapeutics Production
  • 3.5.1 Europe Retinal Vein Occlusion Therapeutics Production Growth Rate (2014-2019)
  • 3.5.2 Europe Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Retinal Vein Occlusion Therapeutics Production (2014-2019)
  • 3.6.1 China Retinal Vein Occlusion Therapeutics Production Growth Rate (2014-2019)
  • 3.6.2 China Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Retinal Vein Occlusion Therapeutics Production (2014-2019)
  • 3.7.1 Japan Retinal Vein Occlusion Therapeutics Production Growth Rate (2014-2019)
  • 3.7.2 Japan Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Retinal Vein Occlusion Therapeutics Consumption by Regions

• 4.1 Global Retinal Vein Occlusion Therapeutics Consumption by Regions
• 4.2 North America Retinal Vein Occlusion Therapeutics Consumption (2014-2019)
• 4.3 Europe Retinal Vein Occlusion Therapeutics Consumption (2014-2019)
• 4.4 China Retinal Vein Occlusion Therapeutics Consumption (2014-2019)
• 4.5 Japan Retinal Vein Occlusion Therapeutics Consumption (2014-2019)

5 Global Retinal Vein Occlusion Therapeutics Production, Revenue, Price Trend by Type

• 5.1 Global Retinal Vein Occlusion Therapeutics Production Market Share by Type (2014-2019)
• 5.2 Global Retinal Vein Occlusion Therapeutics Revenue Market Share by Type (2014-2019)
• 5.3 Global Retinal Vein Occlusion Therapeutics Price by Type (2014-2019)
• 5.4 Global Retinal Vein Occlusion Therapeutics Production Growth by Type (2014-2019)

6 Global Retinal Vein Occlusion Therapeutics Market Analysis by Applications

• 6.1 Global Retinal Vein Occlusion Therapeutics Consumption Market Share by Application (2014-2019)
• 6.2 Global Retinal Vein Occlusion Therapeutics Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Retinal Vein Occlusion Therapeutics Business

• 7.1 Acucela Inc
  • 7.1.1 Acucela Inc Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.1.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.1.3 Acucela Inc Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Addmedica SAS
  • 7.2.1 Addmedica SAS Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.2.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.2.3 Addmedica SAS Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Aerpio Therapeutics Inc
  • 7.3.1 Aerpio Therapeutics Inc Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.3.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.3.3 Aerpio Therapeutics Inc Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Annexin Pharmaceuticals AB
  • 7.4.1 Annexin Pharmaceuticals AB Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.4.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.4.3 Annexin Pharmaceuticals AB Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Chengdu Kanghong Pharmaceuticals Group Co Ltd
  • 7.5.1 Chengdu Kanghong Pharmaceuticals Group Co Ltd Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.5.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.5.3 Chengdu Kanghong Pharmaceuticals Group Co Ltd Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Clearside BioMedical Inc
  • 7.6.1 Clearside BioMedical Inc Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.6.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.6.3 Clearside BioMedical Inc Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Formycon AG
  • 7.7.1 Formycon AG Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.7.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.7.3 Formycon AG Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Graybug Vision Inc
  • 7.8.1 Graybug Vision Inc Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.8.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.8.3 Graybug Vision Inc Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Kala Pharmaceuticals Inc
  • 7.9.1 Kala Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.9.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.9.3 Kala Pharmaceuticals Inc Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Lupin Ltd
  • 7.10.1 Lupin Ltd Retinal Vein Occlusion Therapeutics Production Sites and Area Served
  • 7.10.2 Retinal Vein Occlusion Therapeutics Product Introduction, Application and Specification
  • 7.10.3 Lupin Ltd Retinal Vein Occlusion Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Mabion SA
• 7.12 Novartis AG
• 7.13 Ocular Therapeutix Inc
• 7.14 Ohr Pharmaceutical Inc
• 7.15 Regeneron Pharmaceuticals Inc
• 7.16 SciFluor Life Sciences LLC
• 7.17 ThromboGenics NV

8 Retinal Vein Occlusion Therapeutics Manufacturing Cost Analysis

• 8.1 Retinal Vein Occlusion Therapeutics Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Retinal Vein Occlusion Therapeutics
• 8.4 Retinal Vein Occlusion Therapeutics Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Retinal Vein Occlusion Therapeutics Distributors List
• 9.3 Retinal Vein Occlusion Therapeutics Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Retinal Vein Occlusion Therapeutics Market Forecast

• 11.1 Global Retinal Vein Occlusion Therapeutics Production, Revenue Forecast
  • 11.1.1 Global Retinal Vein Occlusion Therapeutics Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Retinal Vein Occlusion Therapeutics Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Retinal Vein Occlusion Therapeutics Price and Trend Forecast (2019-2025)
• 11.2 Global Retinal Vein Occlusion Therapeutics Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Retinal Vein Occlusion Therapeutics Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Retinal Vein Occlusion Therapeutics Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Retinal Vein Occlusion Therapeutics Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Retinal Vein Occlusion Therapeutics Production, Revenue Forecast (2019-2025)
• 11.3 Global Retinal Vein Occlusion Therapeutics Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Retinal Vein Occlusion Therapeutics Consumption Forecast (2019-2025)
  • 11.3.2 Europe Retinal Vein Occlusion Therapeutics Consumption Forecast (2019-2025)
  • 11.3.3 China Retinal Vein Occlusion Therapeutics Consumption Forecast (2019-2025)
  • 11.3.4 Japan Retinal Vein Occlusion Therapeutics Consumption Forecast (2019-2025)
• 11.4 Global Retinal Vein Occlusion Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Retinal Vein Occlusion Therapeutics Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List